Bexarotene (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Bexarotene drug offered from Mylan Pharmaceuticals Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Bexarotene
SUBSTANCE NAME: BEXAROTENE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, LIQUID FILLED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-07-09
END MARKETING DATE: 0000-00-00


Bexarotene HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBexarotene from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 75(mg/1)
START MARKETING DATE: 2015-07-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-6955_2d1eb4bd-51f9-4c9b-9fb1-0be5e30a3dc5
PRODUCT NDC: 0378-6955
APPLICATION NUMBER: ANDA203174

Other BEXAROTENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional Inc.Bexarotene
Mylan Pharmaceuticals Inc.Bexarotene
Oceanside Pharmaceuticalsbexarotene
Valeant Pharmaceuticals North America LLCTargretin